Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT01166503
Other study ID # 1000005134
Secondary ID
Status Completed
Phase
First received
Last updated
Start date May 2004
Est. completion date April 26, 2018

Study information

Verified date June 2018
Source The Hospital for Sick Children
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

The goal of this study is to determine whether corrective surgery done earlier than the current standard can better improve the visual and eye movement deficits in children with infantile esotropia (crossed eyes in infancy).


Description:

While there is a uniform agreement among pediatric ophthalmologists that most infantile esotropia requires surgical correction, the proper timing of surgery is controversial. In North America, the typical age at surgery ranges from 11-18 months. Unfortunately, despite successful surgical realignment of the eyes, the sensory and eye movement deficits often persist. Recently, some pediatric ophthalmologists have advocated earlier surgery. The rationale for early surgery stems from animal and human research showing that early realignment of the eyes within an early critical period allows normal development of the sensory and eye movement systems.


Recruitment information / eligibility

Status Completed
Enrollment 71
Est. completion date April 26, 2018
Est. primary completion date April 2, 2018
Accepts healthy volunteers No
Gender All
Age group 3 Months to 23 Months
Eligibility Inclusion Criteria:

1. onset of esotropia after 10 weeks of age;

2. constant esotropia = 20° (40 prism diopter or PD) at near (1/3 m) on two examinations, separated by 2-4 weeks; and

3. refractive error = +3.00 diopters (far-sightedness).

Exclusion Criteria:

1. gestational age < 34 weeks;

2. birth weight = 1500 g;

3. ventilator treatment in the newborn period;

4. history of meningitis or other major medical event;

5. developmental delay;

6. incomitant or paralytic strabismus;

7. manifest nystagmus or head bobbing;

8. prior eye muscle surgery;

9. prior treatment of amblyopia or spectacle correction for refractive errors;

10. presence of structural ocular anomalies.

Study Design


Related Conditions & MeSH terms


Intervention

Procedure:
mVEP Testing
Five small sensors are placed on the head which record the brain's response to moving stripes that are displayed on a computer screen. Each eye is tested while the other eye is patched. Each recording trial lasts about 10 seconds, and several trials are done for each eye.
Stereoacuity Testing
Subjects will have their 3D perception measured using standard clinical stereo tests (Randot, Lang, Titmus).
Optokinetic nystagmus testing
Subjects will be asked to view a screen with vertical stripes moving in both leftward and rightward directions while their eye movements are recorded using a remote video-based eye tracker.
Motion detection testing
Subjects will view a computer screen that has two panels of dots on them. The subject will be required to pick which panel has a section of dots that are moving in a specific direction (ie. nasalward/temporalward).
Motion discrimination testing
Subjects will view a computer screen that has two panels of randomly moving dots on them. The subject will be required to pick which panel has a section of dots that are moving in a specific direction (ie. nasalward/temporalward).

Locations

Country Name City State
Canada The Hospital for Sick Children Toronto Ontario

Sponsors (1)

Lead Sponsor Collaborator
The Hospital for Sick Children

Country where clinical trial is conducted

Canada, 

Outcome

Type Measure Description Time frame Safety issue
Primary Motion visual evoked potential (mVEPs) asymmetry mVEP measures the perception of nasalward and temporalward motion for each eye at the cortical level. A nasal bias index (NBI) is calculated, which will show whether subjects perceive motion better for one direction over the other. at age 2 years
Primary Stereopsis This measures the level of 3D depth perception. at 2 and 5 years of age
Primary Optokinetic nystagmus (OKN) asymmetry OKN is measured in both the nasalward and temporalward directions for each eye. From this a nasal bias index (NBI) is calculated, which will show whether subjects perceive motion better in one direction or the other. at age 5 years
Primary Global Motion Perception Motion perception will be tested using two tasks: motion detection (at age 2 and 5 years) and motion discrimination (at age 5 years). at 2 and 5 years of age
See also
  Status Clinical Trial Phase
Not yet recruiting NCT05527015 - Bifocal Spectacles vs. Single Vision Spectacles for Esotropia Greater at Near Phase 3
Completed NCT00746304 - Long-Term Outcomes in the Treatment of Infantile and Acquired Esotropia With Botulinum Toxin N/A
Completed NCT01460355 - Comparison of Two Treatments for Strabismus Correction: Botulinum Toxin A Associated to Surgery and Surgery Alone Phase 4
Recruiting NCT06077682 - Cycloplegic Refraction in Pediatric Patients With Esotropia Phase 4
Completed NCT02570555 - Strabismus Surgery and Driving Ability
Active, not recruiting NCT00993174 - Surgery for Esotropia Under Topical Anesthesia N/A
Completed NCT00000121 - The Prism Adaptation Study (PAS) Phase 3
Active, not recruiting NCT02404324 - Conservative Treatment of Esotropia in Children up to 3 Years Old N/A
Completed NCT04429659 - Changes in Refractive Error in Patients With Both Partially Refractive Esotropia and Amblyopia
Recruiting NCT05615519 - Validation of a Smartphone-based Intelligent Diagnosis and Measurement for Strabismus
Completed NCT00000163 - Congenital Esotropia Observational Study (CEOS) N/A
Recruiting NCT01616108 - Bupivacaine Injection of Eye Muscles to Treat Strabismus Phase 2/Phase 3